Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,045Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 115 of the 116 references it cites were found in a registry or an index, and 1 are not checked yet.

Blood-based biomarkers for Alzheimer's disease: towards clinical implementation

Open access
Teunissen, Charlotte E, Verberk, Inge M W, Thijssen, Elisabeth H, Vermunt, Lisa, Hansson, Oskar, Zetterberg, Henrik, van der Flier, Wiesje M, Mielke, Michelle M, del Campo, Marta·2022·The Lancet Neurology

Abstract

For many years, blood-based biomarkers for Alzheimer's disease seemed unattainable, but recent results have shown that they could become a reality. Convincing data generated with new high-sensitivity assays have emerged with remarkable consistency across different cohorts, but also independent of the precise analytical method used. Concentrations in blood of amyloid and phosphorylated tau proteins associate with the corresponding concentrations in CSF and with amyloid-PET or tau-PET scans. Moreover, other blood-based biomarkers of neurodegeneration, such as neurofilament light chain and glial fibrillary acidic protein, appear to provide information on disease progression and potential for monitoring treatment effects. Now the question emerges of when and how we can bring these biomarkers to clinical practice. This step would pave the way for blood-based biomarkers to support the diagnosis of, and development of treatments for, Alzheimer's disease and other dementias.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(21)00361-6

Cites

115 of 116 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 115 references

Research works printed but not linked: 1

  1. Verberk IMW, Misdorp EO, Koelewijn J, et al. Characterization of pre-analytical sample handling effects on a panel of Alzheimer's-related blood-based biomarkers. Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group. Alzheimer's Dement (in press).

Cited by

See all 1,045

Metadata

Authors
Teunissen, C. E., Verberk, I. M. W., Thijssen, E. H., Vermunt, L., Hansson, O., Zetterberg, H., van der Flier, W. M., Mielke, M. M., & del Campo, M.
Affiliations
  • Amsterdam Neuroscience (NL)
  • Lund University (SE)
  • Sahlgrenska University Hospital (SE)
  • Mayo Clinic (US)
Corresponding author
Teunissen, Charlotte E
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2022-01
Volume
21
Issue
1
Pages
66-77
ISSN
1474-4422 (ISSN-L)
OpenAlex
W3215066238
Cited by
1,045
References
115
Citations by year
2026: 229 · 2025: 218 · 2024: 265 · 2023: 214 · 2022: 116
FWCI
26.56
Type
journal article
Language
en
Open access
Locations
  • The Lancet Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, cc-by-nc-nd)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion, cc-by-nc-nd)
  • UCL Discovery (University College London) (submittedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, cc-by-nc-nd)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
National Institute on Aging (U01AG006786, U54AG044170, P30AG062677)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, blood-based biomarkers, amyloid, phosphorylated tau, neurofilament light chain, glial fibrillary acidic protein, cerebrospinal fluid biomarkers, amyloid PET, tau PET, neurodegeneration, treatment monitoring, clinical implementation, dementia diagnosis
MeSH terms
Alzheimer Disease, Humans, Biomarkers, Amyloid beta-Peptides, tau Proteins, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blood-based biomarkers for Alzheimer's disease: towards clinical implementation. https://app.cochat.ai/papers/10.1016/s1474-4422(21)00361-6
The paper
Teunissen, C. E., Verberk, I. M. W., Thijssen, E. H., Vermunt, L., Hansson, O., Zetterberg, H., van der Flier, W. M., Mielke, M. M., & del Campo, M. (2022). Blood-based biomarkers for Alzheimer's disease: towards clinical implementation. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(21)00361-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.